| http://www.w3.org/ns/prov#value | - Use according to claim 25, wherein at least one immunoglobulin, FcR antibodies or fragments of antibodies or synthetic constructs including peptides directed to FcR is used in the manufacture of a pharmaceutical preparation for blocking or cross-linking FcR cross-linking. 28.
|
